Status:

COMPLETED

Duloxetine for the Treatment of Dysthymia

Lead Sponsor:

Stanford University

Collaborating Sponsors:

Eli Lilly and Company

Conditions:

Depressive Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to test the hypothesis that duloxetine (Cymbalta), in doses of 60 or 120 mg/day, is an effective and tolerable treatment for adult outpatients suffering from dysthymia. Dy...

Detailed Description

The purpose of this research is to obtain information on the safety and effectiveness of duloxetine (Cymbalta) in the treatment of dysthymia. Duloxetine has been approved by the federal Food and Drug ...

Eligibility Criteria

Inclusion

  • :
  • Sign an informed consent form
  • 18 years of age or older
  • Females not pregnant or breastfeeding or planning pregnancy and using an acceptable form of contraception
  • Meet DSM-IV criteria for dysthymia
  • A screening IDS-C score of 17 or greater
  • No history of serious or unstable medical disorder
  • Not taking any significant concurrent medications
  • Not currently receiving psychotherapy

Exclusion

  • Suffering from DSM-IV defined
  • delirium, dementia, amnestic, or other cognitive disorders
  • mental disorders due to a general medical condition
  • factitious or somatoform disorders
  • mental retardation or developmental disabilities
  • substance or alcohol abuse within the last 3 months
  • depressive disorders with current suicidal risk
  • psychotic disorders including delusional disorder, somatic type
  • dissociative disorder
  • personality disorders sufficiently severe to interfere with study participation
  • History of DSM-IV defined bipolar I or II disorder
  • History of non-response of dysthymia to adequate antidepressant medication
  • History of major depression refractory to two adequate trials of antidepressants

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2006

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00185575

Start Date

September 1 2004

End Date

April 1 2006

Last Update

April 9 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University School of Medicine

Stanford, California, United States, 94305